Glut-1 as a novel target for anticancer therapy: A compare analysis using the NCI panel of 60 cell lines

被引：0
|
作者：
Evans, A [1 ]
Hewitt, S [1 ]
Stratford, IJ [1 ]
Airley, RE [1 ]
机构：
[1] Liverpool John Moores Univ, Sch Pharm & Chem, Liverpool L3 5UX, Merseyside, England
来源：
BRITISH JOURNAL OF CANCER | 2003年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 24 条
  • [1] Analysis of Food and Drug Administration-Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines
    Holbeck, Susan L.
    Collins, Jerry M.
    Doroshow, James H.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (05) : 1451 - 1460
  • [2] Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies
    Evans, Andrew
    Bates, Victoria
    Troy, Helen
    Hewitt, Stephen
    Holbeck, Susan
    Chung, Yuen-Li
    Phillips, Roger
    Stubbs, Marion
    Griffiths, John
    Airley, Rachel
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (03) : 377 - 393
  • [3] Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies
    Andrew Evans
    Victoria Bates
    Helen Troy
    Stephen Hewitt
    Susan Holbeck
    Yuen-Li Chung
    Roger Phillips
    Marion Stubbs
    John Griffiths
    Rachel Airley
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 377 - 393
  • [4] Analysis of Food and Drug Administration-Approved Anticancer Agents in the NCI60 Panel of Human Tumor Cell Lines (vol 9, pg 1451, 2010)
    Holbeck, S. L.
    Collins, J. M.
    Doroshow, J. H.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (06) : 1927 - 1927
  • [5] Prediction of anticancer molecules using hybrid model developed on molecules screened against NCI-60 cancer cell lines
    Harinder Singh
    Rahul Kumar
    Sandeep Singh
    Kumardeep Chaudhary
    Ankur Gautam
    Gajendra P. S. Raghava
    BMC Cancer, 16
  • [6] Prediction of anticancer molecules using hybrid model developed on molecules screened against NCI-60 cancer cell lines
    Singh, Harinder
    Kumar, Rahul
    Singh, Sandeep
    Chaudhary, Kumardeep
    Gautam, Ankur
    Raghava, Gajendra P. S.
    BMC CANCER, 2016, 16
  • [7] Analysis of gene expression data of the NCI 60 cancer cell lines using Bayesian hierarchical effects model
    Lee, JK
    Scherf, U
    Smith, LH
    Tanabe, L
    Weinstein, JN
    MICROARRAYS: OPTICAL TECHNOLOGIES AND INFORMATICS, 2001, 4266 : 228 - 235
  • [8] Deregulated glucose transport as a target for anticancer drug development: use of a Glut-1 over-expressing colon carcinoma cell line to screen tyrosine kinase inhibitors for Glut-1-dependent toxicity
    Hodgson, G.
    Evans, A.
    Airley, R.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 : S76 - S76
  • [9] Esters of Quinoxaline 1, 4-Di-N-oxide with Cytotoxic Activity on Tumor Cell Lines Based on NCI-60 Panel
    Rivera, Gildardo
    Shah, Syed Shoaib Ahmad
    Arrieta-Baez, Daniel
    Palos, Isidro
    Mongue, Antonio
    Sanchez-Torres, Luvia Enid
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (03): : 953 - 965
  • [10] Analysis of Pathway Activity in Primary Tumors and NCI60 Cell Lines Using Gene Expression Profiling Data
    Jonathan M. Yingling
    Lawrence M. Gelbert
    Eric W. Su
    Jude E. Onyia
    Genomics Proteomics & Bioinformatics, 2007, (01) : 15 - 24
123